Skadden, Arps, Slate, Meagher & Flom and Han Kun Law Offices have advised Chinese health-tech company Yidu Tech on its HK$4.1 billion ($531 million) initial public offering on the Hong Kong Stock Exchange, with Slaughter and May and Haiwen & Partners representing the joint sponsors and underwriters.

Yidu Tech provides big data and artificial intelligence-based solutions to the healthcare industry. According to Bloomberg, Yidu Tech’s Hong Kong debut attracted Tencent and seven other cornerstone investors, who committed to buying about $210 million of stock.

Last year saw a flurry of Chinese companies in the pharmaceutical/healthcare sector listing in Hong Kong. They included JD Health International, Antengene Corporation and Simcere Pharmaceutical Group.

The Skadden team was led by partners Julie Gao, Christopher Betts, Shu Du and Paloma Wang.

Meanwhile, partners John Moore and Clara Choi led the Slaughter and May team.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

Skadden, Jia Yuan, Freshies, KWM act on Midea’s $3.5 bln HK share offering

by Asian Legal Business《亚洲法律杂志》 |

Skadden, Arps, Slate, Meagher & Flom and Jia Yuan Law Offices are advising Chinese home appliance maker Midea Group on its HK$26.97 billion ($3.46 billion) share offering in Hong Kong, the city's largest listing in more than three years.

Deals

Skadden, STB advise on Timee’s $435mln Japan IPO

by Nimitt Dixit |

U.S. law firm Skadden, Arps, Slate, Meagher & Flom has guided Timee, Inc, a Japanese on-demand job platform, on its $435 million initial public offering and listing on the Tokyo Stock Exchange. Simpson Thacher & Bartlett advised the international managers on the deal.

Deals

Skadden, Latham act on $1.1 bln Japan outbound pharma deal

by Asian Legal Business《亚洲法律杂志》 |

Skadden, Arps, Slate, Meagher & Flom has advised Japan's Otsuka Pharmaceutical on its $1.1 billion agreement to acquire Boston-based Jnana Therapeutics, which was represented by Latham & Watkins.